Insulin Degludec Dosing and Treatment Plan for Type 1 and Type 2 Diabetes
Combination Therapy Options
- When basal insulin has been titrated to an acceptable fasting blood glucose but HbA1c remains above target, consider advancing to combination injectable therapy, as recommended by the American Diabetes Association, 1
- In type 2 diabetes, if basal insulin alone is insufficient, combination with a GLP-1 receptor agonist can be considered before advancing to multiple daily injections, according to the American Diabetes Association, 1
- Fixed combination products containing insulin degludec plus liraglutide (IDegLira) are available and may simplify treatment, as noted by the American Diabetes Association, 1
- When initiating combination injectable therapy, metformin therapy should be maintained, while sulfonylureas and DPP-4 inhibitors are typically discontinued, as recommended by the American Diabetes Association, 1
- For patients requiring complex insulin regimens, adjunctive use of SGLT2 inhibitors may help improve control and reduce insulin requirements, according to the American Diabetes Association, 1 and other sources, 4